← Back
Pulmonx
LUNG · listed on Nasdaq · worth $77.29 million
$3.01
−4.77% today
No insider bought Pulmonx stock in the last year. They sold it 25 times, $263.3K in all.
Red dot = an insider sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
37.6M shares
89% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, five insiders sold Pulmonx stock and none bought. None of the 25 sales is marked on its filing as planned in advance; most by company executives. The biggest seller was Glendon E. French III, President and CEO.
Big investors
People and funds that reported owning 5% or more of Pulmonx, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateMorgan Stanley6.9%Aug 13
All reports
Every insider trade and SEC report we hold for Pulmonx.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Sep 3SoldSrikanth RadhakrishnanSep 3 · Traded Sep 1 · Chief Science & Techn. Officer5,863 @ $2.26$13.3K
Sep 3SoldSrikanth RadhakrishnanSep 3 · Traded Sep 1 · Chief Science & Techn. Officer3,618 @ $2.26$8.2K
Sep 3SoldSrikanth RadhakrishnanSep 3 · Traded Sep 1 · Chief Science & Techn. Officer2,121 @ $2.26$4.8K
48 more with Pro →Analysts, earnings and news
Analysts' price target
$3.40 average
5 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q1 '26−$0.33 a share−$0.00
Q4 '25−$0.25 a share+$0.14
Q3 '25−$0.34 a share+$0.08
Q2 '25−$0.38 a share+$0.02